Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print

Ask The Experts

July 17, 2013
Stability testing for a licensed compound  Read More »
March 6, 2013
How will CMOs deal with new regulations to limit the strength of prescription acetominophen?  Read More »
March 6, 2013
How do I assess and convey the value of a novel protein expression system?  Read More »
March 6, 2013
What are the common biocompatibility tests that drug companies must perform during new drug development?  Read More »
January 22, 2013
What are the top concerns when choosing a clinical trial site in developed or emerging markets, and do cheaper prices in emerging markets outweigh those concerns?  Read More »
January 22, 2013
How do I get my foot in the door for a first job in pharma?  Read More »
October 26, 2012
What EU customs/regulatory database is of most use?  Read More »
Gil Roth
October 26, 2012
What is the best way to communicate with customs officials?  Read More »
Gil Roth
October 26, 2012
Cold Chain is becoming more prevalent in clinical trials. What measures can we take to prevent deviations?  Read More »
Gil Roth
October 26, 2012
What is an IoR?  Read More »
October 5, 2012
What level of GMP need to be followed for clinical trial materials (for a generic ANDA) intended for animal studies if the drug is already in the market?  Read More »
October 5, 2012
Do you agree that the trend within clinical trials is moving towards using controlled ambient containers for regular room temperature shipments?  Read More »
October 5, 2012
What is the current industry average (in percentage) of API and formulation outsourcing in emerging markets?  Read More »
October 5, 2012
Is too much regulation killing drug development?  Read More »
October 5, 2012
What homework will you do to try to assess the cost of a new outsourcing project?  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On